Pimozide

FDA Approved: * September 28, 2015
Pharm Company: * PAR PHARM
Category: Antipsychotic

Pimozide (sold under the brand name Orap) is an antipsychotic drug of the diphenylbutylpiperidine class. It was discovered at Janssen Pharmaceutica in 1963. It has a high potency compared to chlorpromazine (ratio 50-70:1). On a weight basis it is even more potent than haloperidol. It also has special neurologic indications for Tourette syndrome and resistant tics. The side effects include akathisia, tardive dyskinesia, and, more rarely, neuroleptic malignant syndrome and prolongation of the Q... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Pimozide 1 mg Oral Tablet
NDC: 49884-347
Labeler:
Par Pharmaceutical Companies, Inc.
Pimozide 2 mg Oral Tablet
NDC: 49884-348
Labeler:
Par Pharmaceutical Companies, Inc.
Pimozide 2 mg Oral Tablet
NDC: 69189-0462
Labeler:
Avera Mckennan Hospital

Related Brands

Drugs with the same active ingredients